Galera Therapeutics, Inc. Profile Avatar - Palmy Investing

Galera Therapeutics, Inc.

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419…

Biotechnology
US, Malvern [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Galera Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Galera Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Galera Therapeutics, Inc..

End of GRTX's Analysis
CIK: 1563577 CUSIP: 36338D108 ISIN: US36338D1081 LEI: - UEI: -
Secondary Listings
GRTX has no secondary listings inside our databases.